Sarepta Therapeutics Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (54)

Latest Posts

About This Stock More About This Stock
5 Gene Therapy Stocks Back In Focus On AbbVie/Regenxbio Deal
Article By: Zacks Investment Research
Tuesday, September 14, 2021 3:32 PM EDT
Gene therapy is set to become one of the most vital spaces with high prospects in the biotech sector.
In this article: SRPT, QURE, SLDB, MGTX, VYGR Also: ABBV, RGNX
Read
Biotech Bloodbath: Hedge Fund Hotel Sarepta Collapses After Study Disappoints
Article By: Tyler Durden
Thursday, January 7, 2021 6:59 PM EDT
Sarepta, the hedge-fund-hotel has done it again, collapsing over 50% after hours following reports that a key study from the industry leader missed lofty investor expectations.
In this article: SRPT
Read
Sarepta Price Target Raised To $260 From $160 At H.C. Wainwright
Article By: The Fly
Friday, December 13, 2019 8:06 AM EDT
H.C. Wainwright analyst Debjit Chattopadhyay raised his price target for Sarepta Therapeutics to $260 from $160 after the FDA reversed course and approved Vyondys 53.
In this article: SRPT
Read
Biotech Scoreboard, November: Gene Therapy Stocks Gain Momentum
Article By: Rod Raynovich
Saturday, November 30, 2019 11:38 PM EDT
IBB is up 11.2% for November, XBI up 6.3%, but NASDAQ-100 (QQQ) leads up 14.5 %. The big winners for the month include NTLA up 47.24%.
In this article: IBB, QQQ, XBI, SRPT, NTLA, CRSP
Read
Biotech (Top 30 Weights) 2019 Earnings Estimates Up 8.58% In Last 2 Months
Article By: T.J. Hayes
Monday, September 9, 2019 7:36 PM EDT
The cumulative earnings power of these 30 stocks was revised UP by 8.58% in the past 60 days.
In this article: ALNY, ALXN, BMRN, CBPO, ILMN, INCY, JAZZ, REGN, SGEN, AMGN, BIIB, CELG, EXEL, GILD, HZNP, MYL, NBIX, TECH, VRTX, AMRN, SAGE, GWPH, SRPT, BLUE, NVCR, IONS, BGNE, PRAH, SYNH, IBB
Read

Latest Tweets for $SRPT

No tweets yet!

PARTNER HEADLINES

$SRPT

Why Sarepta Therapeutics Inc Looks On Track For A Second DMD Approval
Carol Klein 10/11/2017 1:39:12 PM

Looks promising, thanks. $SRPT.

1 to 1 of 1 comments